Journal articles on the topic 'Cardiac hypertrophy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Cardiac hypertrophy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Li, Wei-ming, Yi-fan Zhao, Guo-fu Zhu, Wen-hui Peng, Meng-yun Zhu, Xue-jing Yu, Wei Chen, Da-chun Xu, and Ya-wei Xu. "Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload." Clinical Science 131, no. 2 (December 23, 2016): 141–54. http://dx.doi.org/10.1042/cs20160664.
Full textWehbe, Nadine, Suzanne Nasser, Gianfranco Pintus, Adnan Badran, Ali Eid, and Elias Baydoun. "MicroRNAs in Cardiac Hypertrophy." International Journal of Molecular Sciences 20, no. 19 (September 23, 2019): 4714. http://dx.doi.org/10.3390/ijms20194714.
Full textStrøm, Claes C., Mogens Kruhøffer, Steen Knudsen, Frank Stensgaard-Hansen, Thomas E. N. Jonassen, Torben F. Ørntoft, Stig Haunsø, and Søren P. Sheikh. "Identification of a Core Set of Genes That Signifies Pathways Underlying Cardiac Hypertrophy." Comparative and Functional Genomics 5, no. 6-7 (2004): 459–70. http://dx.doi.org/10.1002/cfg.428.
Full textBazgir, Farhad, Julia Nau, Saeideh Nakhaei-Rad, Ehsan Amin, Matthew J. Wolf, Jeffry J. Saucerman, Kristina Lorenz, and Mohammad Reza Ahmadian. "The Microenvironment of the Pathogenesis of Cardiac Hypertrophy." Cells 12, no. 13 (July 4, 2023): 1780. http://dx.doi.org/10.3390/cells12131780.
Full textZhang, Yan, Qiang Da, Siyi Cao, Ke Yan, Zhiguang Shi, Qing Miao, Chen Li, et al. "HINT1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing HOXA5 (Homeobox A5) Expression." Circulation 144, no. 8 (August 24, 2021): 638–54. http://dx.doi.org/10.1161/circulationaha.120.051094.
Full textLu, Peilei, Danyu Zhang, Fan Ding, Jialu Ma, Yang K. Xiang, and Meimi Zhao. "Silencing of circCacna1c Inhibits ISO-Induced Cardiac Hypertrophy through miR-29b-2-5p/NFATc1 Axis." Cells 12, no. 12 (June 19, 2023): 1667. http://dx.doi.org/10.3390/cells12121667.
Full textLi, Yuhao, Yoshihiko Saito, Koichiro Kuwahara, Xianglu Rong, Ichiro Kishimoto, Masaki Harada, Yuichiro Adachi, et al. "Guanylyl Cyclase-A Inhibits Angiotensin II Type 2 Receptor-Mediated Pro-Hypertrophic Signaling in the Heart." Endocrinology 150, no. 8 (April 16, 2009): 3759–65. http://dx.doi.org/10.1210/en.2008-1353.
Full textLi, Yu, Bo He, Chao Zhang, Yanji He, Tianyang Xia, and Chunyu Zeng. "Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway." Nutrients 15, no. 6 (March 9, 2023): 1340. http://dx.doi.org/10.3390/nu15061340.
Full textJohansson, Markus, Benyapa Tangruksa, Sepideh Heydarkhan-Hagvall, Anders Jeppsson, Peter Sartipy, and Jane Synnergren. "Data Mining Identifies CCN2 and THBS1 as Biomarker Candidates for Cardiac Hypertrophy." Life 12, no. 5 (May 12, 2022): 726. http://dx.doi.org/10.3390/life12050726.
Full textHu, Chengyun, Feibiao Dai, Jiawu Wang, Lai Jiang, Di Wang, Jie Gao, Jun Huang, et al. "Peroxiredoxin-5 Knockdown Accelerates Pressure Overload-Induced Cardiac Hypertrophy in Mice." Oxidative Medicine and Cellular Longevity 2022 (January 29, 2022): 1–12. http://dx.doi.org/10.1155/2022/5067544.
Full textRaghunathan, Suchi, Ramesh K. Goyal, and Bhoomika M. Patel. "Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy." Canadian Journal of Physiology and Pharmacology 95, no. 3 (March 2017): 260–67. http://dx.doi.org/10.1139/cjpp-2016-0542.
Full textGallo, Simona, Annapia Vitacolonna, Alessandro Bonzano, Paolo Comoglio, and Tiziana Crepaldi. "ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy." International Journal of Molecular Sciences 20, no. 9 (May 1, 2019): 2164. http://dx.doi.org/10.3390/ijms20092164.
Full textJohansson, Markus, Benjamin Ulfenborg, Christian X. Andersson, Sepideh Heydarkhan-Hagvall, Anders Jeppsson, Peter Sartipy, and Jane Synnergren. "Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy." Life 12, no. 2 (February 16, 2022): 293. http://dx.doi.org/10.3390/life12020293.
Full textBi, Hai-Lian, Xiao-Li Zhang, Yun-Long Zhang, Xin Xie, Yun-Long Xia, Jie Du, and Hui-Hua Li. "The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor." Science Advances 6, no. 16 (April 2020): eaax4826. http://dx.doi.org/10.1126/sciadv.aax4826.
Full textDeng, Yawen, Zhitong Li, Xiangbo An, Rui Fan, Yao Wang, Jiatian Li, Xiaolei Yang, Jiawei Liao, and Yunlong Xia. "Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension." Oxidative Medicine and Cellular Longevity 2022 (August 22, 2022): 1–16. http://dx.doi.org/10.1155/2022/1486157.
Full textGu, Wei, Yutong Cheng, Su Wang, Tao Sun, and Zhizhong Li. "PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2." Cardiovascular Toxicology 21, no. 6 (February 21, 2021): 451–61. http://dx.doi.org/10.1007/s12012-021-09639-0.
Full textGolomb, E., Z. A. Abassi, G. Cuda, M. Stylianou, V. R. Panchal, D. Trachewsky, and H. R. Keiser. "Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats." American Journal of Physiology-Heart and Circulatory Physiology 267, no. 4 (October 1, 1994): H1496—H1506. http://dx.doi.org/10.1152/ajpheart.1994.267.4.h1496.
Full textHarmsen, Eef, and Frans H. H. Leenen. "Dietary sodium induced cardiac hypertrophy." Canadian Journal of Physiology and Pharmacology 70, no. 4 (April 1, 1992): 580–86. http://dx.doi.org/10.1139/y92-073.
Full textCooper, George. "Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction." American Journal of Physiology-Heart and Circulatory Physiology 291, no. 3 (September 2006): H1003—H1014. http://dx.doi.org/10.1152/ajpheart.00132.2006.
Full textGao, Si, Xue-ping Liu, Li-hua Wei, Jing Lu, and Peiqing Liu. "Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy." Canadian Journal of Physiology and Pharmacology 96, no. 4 (April 2018): 352–58. http://dx.doi.org/10.1139/cjpp-2017-0282.
Full textLi, Peng-Long, Hui Liu, Guo-Peng Chen, Ling Li, Hong-Jie Shi, Hong-Yu Nie, Zhen Liu, et al. "STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy." Hypertension 76, no. 4 (October 2020): 1219–30. http://dx.doi.org/10.1161/hypertensionaha.120.14752.
Full textTappia, Paramjit, Vijayan Elimban, and Naranjan Dhalla. "Involvement of phospholipase C in the norepinephrine-induced hypertrophic response in Cardiomyocytes." Scripta Medica 53, no. 2 (2022): 149–57. http://dx.doi.org/10.5937/scriptamed53-36527.
Full textXie, Xin, Hai-Lian Bi, Song Lai, Yun-Long Zhang, Nan Li, Hua-Jun Cao, Ling Han, Hong-Xia Wang, and Hui-Hua Li. "The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation." Science Advances 5, no. 5 (May 2019): eaau0495. http://dx.doi.org/10.1126/sciadv.aau0495.
Full textRuzicka, M., and F. H. Leenen. "Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats." American Journal of Physiology-Heart and Circulatory Physiology 265, no. 5 (November 1, 1993): H1551—H1556. http://dx.doi.org/10.1152/ajpheart.1993.265.5.h1551.
Full textSari, Nurmila, Yasufumi Katanasaka, Hiroki Honda, Yusuke Miyazaki, Yoichi Sunagawa, Masafumi Funamoto, Kana Shimizu, et al. "Cacao Bean Polyphenols Inhibit Cardiac Hypertrophy and Systolic Dysfunction in Pressure Overload-induced Heart Failure Model Mice." Planta Medica 86, no. 17 (July 9, 2020): 1304–12. http://dx.doi.org/10.1055/a-1191-7970.
Full textChung, Eunhee, Fan Yeung, and Leslie A. Leinwand. "Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation." Journal of Applied Physiology 112, no. 9 (May 1, 2012): 1564–75. http://dx.doi.org/10.1152/japplphysiol.00027.2012.
Full textLiu, Yao-Lung, Chiu-Ching Huang, Chiz-Chung Chang, Che-Yi Chou, Shih-Yi Lin, I.-Kuan Wang, Dennis Jine-Yuan Hsieh, Gwo-Ping Jong, Chih-Yang Huang, and Chao-Min Wang. "Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment." Cardiorenal Medicine 5, no. 2 (2015): 79–88. http://dx.doi.org/10.1159/000371454.
Full textKee, Hae Jin, and Hyun Kook. "Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy." Journal of Biomedicine and Biotechnology 2011 (2011): 1–10. http://dx.doi.org/10.1155/2011/928326.
Full textZeng, Si-yu, Qiu-jiang Yan, Li Yang, Qing-hua Mei, and Hui-qin Lu. "Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2." Mediators of Inflammation 2020 (August 4, 2020): 1–14. http://dx.doi.org/10.1155/2020/1078365.
Full textLi, Shujun, Bo Huang, Changfei Zhou, Jingshan Shi, Qin Wu, and Qingsong Jiang. "Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II." Evidence-Based Complementary and Alternative Medicine 2021 (January 15, 2021): 1–8. http://dx.doi.org/10.1155/2021/8857329.
Full textGopinath, Bamini, Ronald J. Trent, and Bing Yu. "Molecular characterisation of neonatal cardiac hypertrophy and its regression." Cardiology in the Young 14, no. 5 (October 2004): 498–505. http://dx.doi.org/10.1017/s1047951104005062.
Full textYan, Xiaoying, Ran Zhao, Xiaorong Feng, Jingzhou Mu, Ying Li, Yue Chen, Chunmei Li, et al. "Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway." Cardiovascular Research 116, no. 1 (March 11, 2019): 114–26. http://dx.doi.org/10.1093/cvr/cvz064.
Full textDorn, Lisa E., William Lawrence, Jennifer M. Petrosino, Xianyao Xu, Thomas J. Hund, Bryan A. Whitson, Matthew S. Stratton, et al. "Microfibrillar-Associated Protein 4 Regulates Stress-Induced Cardiac Remodeling." Circulation Research 128, no. 6 (March 19, 2021): 723–37. http://dx.doi.org/10.1161/circresaha.120.317146.
Full textXie, Yifan, Yang Gao, Rifeng Gao, Wenlong Yang, Zheng Dong, Robb E. Moses, Aijun Sun, Xiaotao Li, and Junbo Ge. "The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα–SOD2 pathway." Cell Death & Differentiation 27, no. 10 (May 18, 2020): 2952–72. http://dx.doi.org/10.1038/s41418-020-0554-8.
Full textYu, Qing, Wenxin Kou, Xu Xu, Shunping Zhou, Peipei Luan, Xiaopeng Xu, Hailing Li, et al. "FNDC5/Irisin inhibits pathological cardiac hypertrophy." Clinical Science 133, no. 5 (March 1, 2019): 611–27. http://dx.doi.org/10.1042/cs20190016.
Full textXu, Si-Chi, Zhen-Guo Ma, Wen-Ying Wei, Yu-Pei Yuan, and Qi-Zhu Tang. "Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis." PPAR Research 2017 (2017): 1–12. http://dx.doi.org/10.1155/2017/5789714.
Full textGeraets, Ilvy M. E., Will A. Coumans, Agnieszka Strzelecka, Patrick Schönleitner, Gudrun Antoons, Francesco Schianchi, Myrthe M. A. Willemars, et al. "Metabolic Interventions to Prevent Hypertrophy-Induced Alterations in Contractile Properties In Vitro." International Journal of Molecular Sciences 22, no. 7 (March 31, 2021): 3620. http://dx.doi.org/10.3390/ijms22073620.
Full textZhang, Ning, Wen-Ying Wei, Zheng Yang, Yan Che, Ya-Ge Jin, Hai-Han Liao, Sha-sha Wang, Wei Deng, and Qi-Zhu Tang. "Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress." Cellular Physiology and Biochemistry 42, no. 4 (2017): 1313–25. http://dx.doi.org/10.1159/000478960.
Full textYao, Rui, Lingyao Kong, Chunlei Yang, Jiaqi Du, Guojun Zhao, and Yapeng Li. "Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages." Oxidative Medicine and Cellular Longevity 2022 (April 26, 2022): 1–13. http://dx.doi.org/10.1155/2022/9469143.
Full textVilleneuve, C., A. Caudrillier, C. Ordener, N. Pizzinat, A. Parini, and J. Mialet-Perez. "Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells." American Journal of Physiology-Heart and Circulatory Physiology 297, no. 2 (August 2009): H821—H828. http://dx.doi.org/10.1152/ajpheart.00345.2009.
Full textLucas, Aline Maria Brito, Joana Varlla de Lacerda Alexandre, Maria Thalyne Silva Araújo, Cicera Edna Barbosa David, Yuana Ivia Ponte Viana, Beatriz Neves Coelho, Francisco Rodrigo Lemos Caldas, Anna Lídia Nunes Varela, Alicia Juliana Kowaltowski, and Heberty Tarso Facundo. "Diazoxide Modulates Cardiac Hypertrophy by Targeting H2O2 Generation and Mitochondrial Superoxide Dismutase Activity." Current Molecular Pharmacology 13, no. 1 (January 15, 2020): 76–83. http://dx.doi.org/10.2174/1874467212666190723144006.
Full textLiu, Yaoqiu, Yahui Shen, Jingai Zhu, Ming Liu, Xing Li, Yumei Chen, Xiangqing Kong, Guixian Song, and Lingmei Qian. "Cardiac-Specific PID1 Overexpression Enhances Pressure Overload-Induced Cardiac Hypertrophy in Mice." Cellular Physiology and Biochemistry 35, no. 5 (2015): 1975–85. http://dx.doi.org/10.1159/000374005.
Full textMontiel, Virginie, Ramona Bella, Lauriane Y. M. Michel, Hrag Esfahani, Delphine De Mulder, Emma L. Robinson, Jean-Philippe Deglasse, et al. "Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxide." Science Translational Medicine 12, no. 564 (October 7, 2020): eaay2176. http://dx.doi.org/10.1126/scitranslmed.aay2176.
Full textWei, Xiangxiang, Jiayu Jin, Jian Wu, Yunquan He, Jieyu Guo, Zhaohua Yang, Liang Chen, et al. "Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway." Cardiovascular Research, June 3, 2023. http://dx.doi.org/10.1093/cvr/cvad086.
Full textKwon, Duk-hwa, Gwang Hyeon Eom, Hae Jin Kee, Yoonseok Nam, Young Kuk Cho, Don-Kyu Kim, Jayoung Koo, et al. "Abstract 071: Estrogen-related Receptor Gamma Induces Cardiac Hypertrophy By Activating Gata4." Circulation Research 113, suppl_1 (August 2013). http://dx.doi.org/10.1161/res.113.suppl_1.a071.
Full textWang, Wei, Nian Liu, Li Xin, Yanfei Ruan, Xin Du, Rong Bai, Jianzeng Dong, and ChangSheng Ma. "RETRACTED ARTICLE: Inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6." Gene Therapy, December 16, 2019. http://dx.doi.org/10.1038/s41434-019-0109-0.
Full textSu, Haibi, Jie Xu, Zhenghua Su, Chenxi Xiao, Jinghuan Wang, Wen Zhong, Chen Meng, Di Yang, and Yizhun Zhu. "Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1α–sXBP1–GATA4 pathway." Cellular and Molecular Life Sciences 80, no. 6 (May 23, 2023). http://dx.doi.org/10.1007/s00018-023-04805-9.
Full textRind, Jubran, Nagib Chalfoun, and Richard McNamara. "Cardiac amyloidosis: The great masquerader." Global Cardiology Science and Practice 2018, no. 2 (July 23, 2018). http://dx.doi.org/10.21542/gcsp.2018.18.
Full textXiao, Zheng, Bin Kong, Hongjie Yang, Chang Dai, Jin Fang, Tianyou Qin, and He Huang. "Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4." Frontiers in Cardiovascular Medicine 7 (November 26, 2020). http://dx.doi.org/10.3389/fcvm.2020.579036.
Full textChen, Wen-Jing, Yan Cheng, Wen Li, Xiao-Kang Dong, Jian-liang Wei, Chuan-Hua Yang, and Yue-Hua Jiang. "Quercetin Attenuates Cardiac Hypertrophy by Inhibiting Mitochondrial Dysfunction Through SIRT3/PARP-1 Pathway." Frontiers in Pharmacology 12 (October 28, 2021). http://dx.doi.org/10.3389/fphar.2021.739615.
Full text